MCCP
NVO

Mission Creek Capital Partners’s Novo Nordisk NVO Stock Holding History

Mission Creek Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+4,300
New +$185K 0.04% 224
2026
Q1 		– Sell
-5,342
Closed -$272K – 232
2025
Q4 		$272K Sell
5,342
-41,468
-89% -$2.12M 0.05% 181
2025
Q3 		$2.6M Buy
46,810
+41,012
+707% +$2.4M 0.51% 50
2025
Q2 		$400K Buy
5,798
+43
+0.7% +$2.92K 0.09% 147
2025
Q1 		$400K Buy
5,755
+105
+2% +$8.67K 0.1% 151
2024
Q4 		$486K Sell
5,650
-12,712
-69% -$1.37M 0.11% 157
2024
Q3 		$2.19M Buy
18,362
+395
+2% +$52.7K 0.51% 57
2024
Q2 		$2.56M Buy
17,967
+6,525
+57% +$865K 0.65% 42
2024
Q1 		$1.47M Buy
11,442
+3,620
+46% +$431K 0.38% 74
2023
Q4 		$809K Sell
7,822
-100
-1% -$9.89K 0.21% 122
2023
Q3 		$720K Sell
7,922
-660
-8% -$58.1K 0.24% 123
2023
Q2 		$694K Sell
8,582
-1,978
-19% -$162K 0.22% 130
2023
Q1 		$840K Sell
10,560
-110
-1% -$7.8K 0.29% 111
2022
Q4 		$722K Sell
10,670
-950
-8% -$55.7K 0.26% 115
2022
Q3 		$579K Sell
11,620
-200
-2% -$10.7K 0.22% 129
2022
Q2 		$659K Hold
11,820
– – 0.22% 127
2022
Q1 		$656K Hold
11,820
– – 0.18% 146
2021
Q4 		$662K Sell
11,820
-400
-3% -$21.7K 0.13% 155
2021
Q3 		$587K Sell
12,220
-480
-4% -$23.2K 0.11% 160
2021
Q2 		$532K Sell
12,700
-200
-2% -$7.75K 0.09% 159
2021
Q1 		$435K Hold
12,900
– – 0.06% 168
2020
Q4 		$451K Hold
12,900
– – 0.14% 153
2020
Q3 		$448K Sell
12,900
-144
-1% -$4.8K 0.18% 139
2020
Q2 		$427K Sell
13,044
-950
-7% -$30.3K 0.22% 106
2020
Q1 		$421K Sell
13,994
-200
-1% -$5.96K 0.23% 98
2019
Q4 		$411K Buy
+14,194
New +$393K 0.19% 126

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mission Creek Capital Partners's NVO Position: Q2 2026 in Review

Mission Creek Capital Partners opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,300 shares worth $206K. The stake represents 0.04% of the portfolio and ranks #224 among its holdings. This is a return to the name: Mission Creek Capital Partners previously reported a position in NVO as recently as Q4 2025.

Mission Creek Capital Partners first reported a position in NVO in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.6M in Q3 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mission Creek Capital Partners held 4,300 shares of Novo Nordisk worth $206K as of Q2 2026.
  • Novo Nordisk was a new Mission Creek Capital Partners position in Q2 2026.
  • Novo Nordisk made up 0.04% of Mission Creek Capital Partners's portfolio in Q2 2026, its #224 holding.
  • Mission Creek Capital Partners first reported a position in Novo Nordisk in Q4 2019 and has held it in 26 quarters since.
  • Mission Creek Capital Partners's Novo Nordisk position peaked at $2.6M in Q3 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.